Omicron-specific mRNA-based booster vaccine, GEMCOVAC®-OM, launched
1 year, 5 months ago

Omicron-specific mRNA-based booster vaccine, GEMCOVAC®-OM, launched

Hindustan Times  

New Delhi: New Delhi: Union Minister of State Science & Technology Jitendra Singh at an event to launch the GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine for COVID-19, in New Delhi, Saturday, June 24, 2023. A booster vaccine targeted at the Omicron variant of Covid-19 and developed by Pune-based Gennova Biopharmaceuticals was launched by earth sciences minister Jitendra Singh on Saturday. “The clinical outcome demonstrates the need for variant-specific vaccines for desired immune response.” Since the outbreak of the Omicron variant, research institutions have been working on variant-specific vaccines, bivalent vaccines and variant-proof vaccines that are expected to be more effective in building immunity against newer strains. British authorities last year cleared a Moderna dose that the company adapted to create immunity against the Omicron variant, which was the first redesigned Covid vaccine.

India Vaccines New Delhi Covid Pti Vaccine Mrna Variant Omicron Dbt Technology Singh Gemcovac  covid19  mrnabased  technology  singh  omicron  launched  booster  india  gemcovacom  variant  vaccine  vaccines  omicronspecific  minister

History of this topic

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 5 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

First Omicron-specific mRNA vaccine from India approved by regulators
1 year, 6 months ago

First Omicron-specific mRNA vaccine from India approved by regulators

The Hindu  

India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM, developed by Pune-based Gennova Biopharmaceuticals Ltd, was approved under emergency use guidelines by the Drug Controller General of India late Monday. Gennova CEO Sanjay Singh said that by the time his company got regulatory approvals for GEMCOVAC-19, the demand for primary doses was largely met by other vaccines, however there …

Covid vaccine mission is a lesson for the world
1 year, 9 months ago

Covid vaccine mission is a lesson for the world

Hindustan Times  

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

Protein-based booster shots help fight Omicron
1 year, 10 months ago

Protein-based booster shots help fight Omicron

China Daily  

A woman receives a booster dose in Chaoyang district of Beijing on July 13, 2022. China has recently rolled out two protein-based COVID-19 vaccines to serve as booster shots against Omicron subvariants, bringing new weapons to China's fight against mutated strains of the virus. The two vaccines are also recommended as a booster for those inoculated with three inactivated vaccines, …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Sinopharm's mRNA Omicron vaccine gets greenlight for trials
1 year, 11 months ago

Sinopharm's mRNA Omicron vaccine gets greenlight for trials

China Daily  

China National Biotec Group, a subsidiary of China National Pharmaceutical Group Co Ltd, announced on Friday that its biotech unit in Shanghai has received regulatory approval for clinical trials of China's first mRNA COVID-19 vaccine targeting the Omicron strains. The approval for Omicron-specific mRNA vaccine clinical trials, granted by the State Drug Administration on Thursday, is a "milestone" in the …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Omicron BF.7: Is mixing Covid vaccines more effective against the new subvariant? What experts say
1 year, 11 months ago

Omicron BF.7: Is mixing Covid vaccines more effective against the new subvariant? What experts say

Hindustan Times  

Amid rising cases of Omicron BF.7 in China and other parts of the world, there has been concerns of a fresh wave triggered by the subvariant in India in the coming months. However, mixing the vaccines has no side effects rather it can boost the immunity and give multiple ways to our immune system to identify the offending virus and …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

CDC Recommends Updated COVID-19 Vaccine Boosters Targeting Omicron Strains
2 years, 3 months ago

CDC Recommends Updated COVID-19 Vaccine Boosters Targeting Omicron Strains

Huff Post  

LOADING ERROR LOADING New COVID-19 boosters that target today’s most common omicron strains are set to begin soon after the Centers for Disease Control and Prevention endorsed the updated shots Thursday. The decision by CDC Director Rochelle Walensky came shortly after the agency’s advisers said if enough people roll up their sleeves, the shots could blunt a winter surge. The …

EU regulator clears tweaked versions of COVID vaccines
2 years, 3 months ago

EU regulator clears tweaked versions of COVID vaccines

Associated Press  

LONDON — The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant. In a statement on Thursday, the EU drug regulator said the two messenger RNA boosters offered protection both against the original version of COVID-19 and the omicron subvariant …

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla
2 years, 3 months ago

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla

News 18  

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday. “The original Novovax vaccine Covovax covers omicron and there is good data for it. We will try to launch Omicron-specific vaccine after six months,” he said. The Pune-based Serum Institute is working with US biotechnology major Novavax …

U.S. authorizes updated COVID-19 boosters targeting newest variants
2 years, 3 months ago

U.S. authorizes updated COVID-19 boosters targeting newest variants

LA Times  

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common Omicron strains. “Give a clear, forward-looking set of expectations.” Here’s the rub: The original vaccines still offer strong protection against severe disease and death from COVID-19 for most generally healthy people, especially if they got that important first booster dose. First, FDA …

US approves updated COVID boosters targeting Omicron variants
2 years, 3 months ago

US approves updated COVID boosters targeting Omicron variants

Al Jazeera  

Drugmaker Pfizer said it has doses ready to ship and can deliver up to 15 million shots by the end of next week. The United States has authorised booster doses of the COVID-19 vaccines that target the most common Omicron strain, and shots could be available within days. “You’ll see me at the front of the line,” FDA vaccine chief …

Omicron-specific COVID-19 booster may be available in a few weeks, officials say
2 years, 4 months ago

Omicron-specific COVID-19 booster may be available in a few weeks, officials say

LA Times  

Michael Stremfel, owner of Flintridge Pharmacy in La Canada, prepares a COVID-19 booster in November 2021. The Omicron-specific COVID-19 booster may be available in a few weeks, assuming federal agencies sign off on the new shot, a top White House COVID-19 official said this week. The booster has been widely expected for months, especially since the latest dominant Omicron subvariant, …

Tackling the new variants
2 years, 4 months ago

Tackling the new variants

Hindustan Times  

The first redesigned coronavirus vaccine was approved for use this week when authorities in the United Kingdom cleared a Moderna dose that the company adapted to create immunity against the Omicron variant. The vaccine is a 50-50 formulation of Moderna’s 2020 product, designed on the Sars-CoV-2 variant that first spread around the world, and of a new dose developed using …

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine
2 years, 5 months ago

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine

India Today  

The Centre has invested in developing a strain specific vaccine that would help in countering the changing nature of coronavirus. An official who facilitated developing this ecosystem for second generation vaccines told India Today that research and development work is underway to develop strain-specific vaccines in India. A bivalent vaccine will target the specific spike mutations seen in the Omicron …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

Yet another highly infectious Omicron variant is raising concerns in India and beyond
2 years, 5 months ago

Yet another highly infectious Omicron variant is raising concerns in India and beyond

LA Times  

The quickly changing coronavirus has spawned yet another super-contagious Omicron mutant that’s worrying scientists as it gains ground in India and pops up in numerous other countries, including the United States. “It’s still really early on for us to draw too many conclusions,” said Matthew Binnicker, director of clinical virology at the Mayo Clinic in Rochester, Minn. “But it does …

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use
2 years, 5 months ago

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use

India TV News  

Highlights GEMCOVAC-19 is the first mRNA vaccine that has been developed in India The company will sell the vaccine under the brand name GEMCOVAC-19 The two-dose vaccine will be administered intramuscularly at 28 days apart India's first indigenously developed mRNA vaccine, GEMCOVAC-19, has been approved for emergency use by the Drug Controller General of India on Tuesday. The vaccine has …

COVID mRNA vaccines can be quickly updated for new variants. So, where's my Omicron booster?
2 years, 6 months ago

COVID mRNA vaccines can be quickly updated for new variants. So, where's my Omicron booster?

ABC  

Since Omicron was declared a variant of concern at the end of November, it quickly swept the globe, becoming the dominant COVID variant in many countries including Australia. The process of tailoring mRNA vaccines for new variants is "very straightforward", says Archa Fox, an RNA biologist at the University of Western Australia. "Only about 10-20 per cent of antibodies bind …

Hyderabad-based CCMB announces first potential mRNA COVID vaccine
2 years, 7 months ago

Hyderabad-based CCMB announces first potential mRNA COVID vaccine

Firstpost  

Dr N Madhusudan Rao, CEO of Atal Incubation Centre at Centre for Cellular and Molecular Biology, said the mRNA platform has an advantage of flexibility unlike other vaccine platforms New Delhi: Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology on Monday said that India has developed mRNA technology against the COVID-19. The Hyderabad-based Centre …

India develops first mRNA vaccine technology to fight Covid-19
2 years, 7 months ago

India develops first mRNA vaccine technology to fight Covid-19

India Today  

India’s first indigenous mRNA vaccine technology to fight against Covid-19 has been developed by the Centre for Cellular and Molecular Biology and Council Of Scientific And Industrial Research. CSIR-Centre for Cellular and Molecular Biology is leading the development of mRNA vaccine technology in India. However, we lack the potent mRNA vaccine technology, as developed by Moderna or Pfizer/BioNtech to combat …

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines
2 years, 8 months ago

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines

Firstpost  

WHO and their partners will work with the Indian government to develop a roadmap and put in place the necessary training and support for Biological E to start producing mRNA vaccines as soon as possible Hyderabad: Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation …

Biological E. to receive mRNA vaccine tech from WHO
2 years, 8 months ago

Biological E. to receive mRNA vaccine tech from WHO

The Hindu  

Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday. The company has been investing in mRNA technologies since last year and …

Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines
2 years, 8 months ago

Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines

NPR  

A vaccine for omicron? Here's what could be next for COVID vaccines Enlarge this image toggle caption Dinendra Haria/SOPA Images/LightRocket via Getty Images Dinendra Haria/SOPA Images/LightRocket via Getty Images Most vaccinated people will probably require yet another COVID-19 vaccine booster shot in the fall, a top Food and Drug Administration official said Monday. Sponsor Message "We could basically wait until …

Clinical trials to begin on two new COVID-19 vaccines developed by Melbourne researchers
2 years, 8 months ago

Clinical trials to begin on two new COVID-19 vaccines developed by Melbourne researchers

ABC  

Clinical trials are set to begin on two new COVID-19 vaccines being developed in Melbourne that researchers say may improve immunity to the Omicron variant. Key points: The clinical trials will involve people who have had three doses of a vaccine The vaccines are different to existing ones as they target the tip of the virus spike protein The vaccines …

Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI
2 years, 9 months ago

Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI

Firstpost  

The company has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity New Delhi: Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India’s first mRNA COVID vaccine to the regulator Drugs Controller General of India on Friday, said sources. “India is heading towards becoming a vaccine superpower and the fact …

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech
2 years, 10 months ago

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech

Firstpost  

The FDA has lifted its clinical hold on Bharat Biotech’s Investigational New Drug application to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States Hyderabad: Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States. “Ocugen, Inc announced that the US Food …

India’s first mRNA COVID-19 vaccine likely to be rolled out by April
2 years, 10 months ago

India’s first mRNA COVID-19 vaccine likely to be rolled out by April

The Hindu  

Data from human trials of India’s first homegrown mRNA COVID-19 vaccine are likely to be presented to authorities for evaluation by the end of the month, and company officials are aiming to roll out the product before April, two senior scientists connected to the Department of Biotechnology told The Hindu. The mRNA vaccine being developed by Pune-based Gennova Biopharmaceuticals is …

India's Gennova Biopharma developing Omicron-specific Covid vaccine: Sources
2 years, 11 months ago

India's Gennova Biopharma developing Omicron-specific Covid vaccine: Sources

India Today  

Gennova Biopharmaceuticals, a Pune-based company which is making India's first mRNA vaccine, has submitted phase-2 trial data of its mRNA Covid-19 vaccine. During his speech at the 76th United Nations General Assembly, Prime Minister Narendra Modi had earlier stated that India’s first mRNA vaccine was in the final stages. The vaccines developed using mRNA techniques teach our cells how to …

EXPLAINED: How India's First Homegrown mRNA Vaccine Can Provide Helping Hand Against Omicron
2 years, 11 months ago

EXPLAINED: How India's First Homegrown mRNA Vaccine Can Provide Helping Hand Against Omicron

News 18  

The country’s first messenger RNA, or mRNA, vaccine, is prepping for launch with the Pune-based Gennova Biopharmaceuticals on course with its human trials, reports say, adding that a variant-specific version is also in the works to tackle the Omicron variant. Emcure Pharmaceuticals says that Gennova, its subsidiary, is “India’s only company to deploy the mRNA platform to develop a vaccine” …

Covaxin booster shot neutralises Omicron, says Bharat Biotech
2 years, 11 months ago

Covaxin booster shot neutralises Omicron, says Bharat Biotech

Hindustan Times  

India's vaccine-maker Bharat Biotech on Wednesday said that a booster dose of its Covid-19 vaccine ‘Covaxin’ neutralises both the Omicron and Delta variants of the coronavirus. The study, "The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant," Reuters quoted Bharat Biotech as saying in a statement. Citing the …

Pfizer Plans To Introduce Hybrid Vaccine Targeting Omicron Variant By March: Reports
2 years, 11 months ago

Pfizer Plans To Introduce Hybrid Vaccine Targeting Omicron Variant By March: Reports

ABP News  

New Delhi: In a new development on the vaccine front, Pfizer Inc is developing a hybrid vaccine that will comprise of the original shot with a formulation that protects against the highly transmissible omicron variant, said the company’s top official. Even as the research continues, Pfizer will evaluate the new hybrid formulation against an omicron-specific shot, and determine which is …

Moderna CEO sees another round of COVID booster jabs in fall
2 years, 11 months ago

Moderna CEO sees another round of COVID booster jabs in fall

Al Jazeera  

Moderna Inc chief Stephane Bancel also said Omicron may move the world rapidly to an endemic phase where most people are exposed to the coronavirus. Moderna Inc. Chief Executive Officer Stephane Bancel said another round of vaccine boosters against Covid-19 will probably be needed this fall, even if immunity to the rapidly spreading omicron variant becomes widespread. Highly infectious omicron …

Vaccines still effective against Omicron, severity of disease not surged: WHO chief scientist
2 years, 11 months ago

Vaccines still effective against Omicron, severity of disease not surged: WHO chief scientist

India TV News  

Vaccines appear to be effective against the Omicron variant because even though the numbers are going up exponentially in many countries, the severity of the disease has not surged to a new level, WHO Chief Scientist Dr. Soumya Swaminathan has said. Referring to the third factor which decides the effectiveness of the vaccine, Swaminathan said, "It is the time since …

Amid Omicron spread, PM Modi to hold Covid-19 review meeting today
3 years ago

Amid Omicron spread, PM Modi to hold Covid-19 review meeting today

Live Mint  

Amid the spread of the Omicron covid variant, Prime Minister Narendra Modi will hold a meeting to review the pandemic situation in the country today, news agency ANI reported. India has recorded 236 cases of the Omicron variant of coronavirus across 16 states and UTs so far out of which 104 people have recovered or migrated, according to the Union …

Amid vaccine booster talk, context matters a lot
3 years ago

Amid vaccine booster talk, context matters a lot

The Hindu  

Nearly four weeks since Omicron was designated as a variant of concern, evidence points to its spreading faster than other variants. Laboratory studies using samples from individuals vaccinated with vaccines made on different platforms, including mRNA, vectored and inactivated vaccines, have reported that the neutralising antibodies are 25 times or much greater times less effective against Omicron than the ancestral …

Data Shows mRNA Vaccines Best Boosters Against Covid, Modi Govt Must Get Them to India: Dr Kang
3 years ago

Data Shows mRNA Vaccines Best Boosters Against Covid, Modi Govt Must Get Them to India: Dr Kang

News 18  

Top vaccine expert Dr Gagandeep Kang has urged the Narendra Modi government to figure out a way to bring mRNA vaccines to India, saying that data shows it to be the best booster shot against Covid-19. However, according to the global data, mRNA vaccines have proven to be the best boosters.” “Either the Indian government should figure out how to …

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48
3 years ago

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48

News 18  

As the World Health Organization grants an emergency approval to Serum Institute of India’s Covovax, a top Indian government scientist has recommended that it be used as a booster shot to counter the threat posed by the emerging omicron variant of coronavirus, India Today reported. French Prime Minister Jean Castex says the Omicron variant will be the dominant strain of …

Covid-19: Over 100 Omicron cases in India, no evidence for now that vaccines won't work, says govt
3 years ago

Covid-19: Over 100 Omicron cases in India, no evidence for now that vaccines won't work, says govt

India Today  

The Union Health Ministry on Friday said that there is no evidence that the vaccines will not work against the Omicron strain of coronavirus. India's tally of Omicron cases crossed the 100 mark on Friday, with fresh cases detected in Maharashtra and Delhi. The government on Friday said that with Omicron variant spreading very fast across Europe and other parts …

Our vaccines may become ineffective, says COVID-19 task force chief as India battles Omicron
3 years ago

Our vaccines may become ineffective, says COVID-19 task force chief as India battles Omicron

Firstpost  

Dr VK Paul hoped that coronavirus in India is possibly moving in the direction of endemicity, where there is a low or moderate level of transmission going on New Delhi: Amid concerns over Omicron, India’s COVID Task Force chief VK Paul on Tuesday said there is a potential scenario that “our vaccines may become ineffective in emerging situations” and emphasised …

Does the Omicron variant make a case for booster doses? | The Hindu Parley podcast
3 years ago

Does the Omicron variant make a case for booster doses? | The Hindu Parley podcast

The Hindu  

If conversations around booster shots to tackle COVID-19 were loud earlier, the emergence of the new variant, Omicron, has ensured that the clamour for booster shots has reached a fever pitch. The Health Minister stressed that India’s priority is to fully vaccinate all adults and not administer booster shots even though adequate vaccines are available. At a recent meeting, the …

Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose
3 years ago

Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose

The Hindu  

Amid growing concerns over the Omicron variant of SARS-CoV-2, a parliamentary committee has recommended that the efficacy of COVID-19 vaccines must be evaluated and the government conduct more research to examine the need for booster doses to contain the new strain. The Parliamentary Standing Committee on Health, which presented its report on Friday, also said that concerns with regard to …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?
3 years ago

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?

ABC  

The Omicron variant has been generating anxiety across the world since being declared a COVID-19 variant of concern by the World Health Organization over the weekend. According to Westmead Institute virologist Tony Cunningham, scientists around the world — including those in Australia — would be looking at whether protective antibodies in the vaccines were "sufficiently high" to cover this strain. …

Only a matter of weeks before new Covid-19 Omicron variant hits Pakistan: Minister
3 years ago

Only a matter of weeks before new Covid-19 Omicron variant hits Pakistan: Minister

India Today  

It is only a matter of few weeks before the new Covid-19 Omicron variant hits Pakistan, the head of Pakistan's anti-coronavirus task force warned on Monday, urging people to get vaccinated to reduce the threat of the potentially more contagious strain that has triggered global panic. The Omicron variant, feared to spread faster and partially reduce vaccine protection, was identified …

Discover Related